Johnson & Johnson vs Insulet Corporation — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
7.8
Bullish
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
PODD
Consensus analyst target of $326.35 is 86% above current price.
Analyst Consensus
BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $326.35 (+86.4%)
23 analysts
Fundamentals
JNJ
PODD
26.3×
Trailing P/E
50.3×
17.9×
Forward P/E
21.7×
21.8%
Profit Margin
9.1%
68.0%
Gross Margin
71.6%
26.4%
ROE
18.1%
9.9%
Revenue Growth
31.2%
-52.9%
Earnings Growth
3.9%
0.33
Beta
1.47
—
Price / Book
—
$546.9B
Market Cap
$12.1B
$146 – $252
52-Week Range
$158 – $355
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →